Monoclonal Antibody 3F8 and Oral Etoposide for the Treatment of Neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Etoposide; Isotretinoin; Monoclonal antibody 3F8
- Indications Neuroblastoma
- Focus Therapeutic Use
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2005 New trial record.